About TracerDx
TracerDx is a company based in Stanford (United States) founded in 2021. TracerDx has raised $7.89 million across 1 funding round. TracerDx operates in a competitive market with competitors including Evergreen Nephrology, Pathalys, AdaptX, Specialty Networks and Bial, among others.
- Headquarter Stanford, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.89 M (USD)
in 1 rounds
-
Latest Funding Round
$7.89 M (USD), Series A
Jul 15, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TracerDx
TracerDx has successfully raised a total of $7.89M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.89 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by TracerDx
Investment portfolio details for TracerDx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TracerDx
Detailed financials for TracerDx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tracerdx Comparisons
Peer comparison for TracerDx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TracerDx
TracerDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evergreen Nephrology, Pathalys, AdaptX, Specialty Networks and Bial, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chronic care management services for kidney diseases are provided.
|
|
| Locked | Locked | Locked |
Biotherapeutics for chronic kidney disease are developed and provided.
|
|
| Locked | Locked | Locked |
Clinical management solutions are provided for healthcare by AdaptX.
|
|
| Locked | Locked | Locked |
Specialty Networks is focused on supporting independent specialty healthcare providers.
|
|
| Locked | Locked | Locked |
Develops and commercializes pharmaceutical products through research and global distribution.
|
|
| Locked | Locked | Locked |
Chronic care management services are provided to patients.
|
Detailed competitors of TracerDx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tracerdx
Complete news archive for TracerDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TracerDx
TracerDx was founded in 2021 and raised its 1st funding round 3 years after it was founded.
TracerDx is headquartered in Stanford, United States. It is registered at Stanford, California, United States.
TracerDx is a funded company, having raised a total of $7.89M across 1 funding round to date.
TracerDx was founded in 2021 and is based in Stanford, United States. Operations are centered in the oncology sector, where disease monitoring services are delivered to support clinical needs. These services focus on tracking cancer progression through diagnostic tools and data analysis. The company maintains a presence in the United States, serving healthcare providers and patients in need of ongoing oncology surveillance.
TracerDx's top competitors include Evergreen Nephrology, Pathalys and AdaptX.